Table 1 Localized PDAC patient characteristics at the time of blood draw for CTC purification.
From: Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target
ID | Age (yrs) | Sex | CA19-9 (U/mL) | CEA (ng/mL) | T stage | N stage | M stage | Stage |
|---|---|---|---|---|---|---|---|---|
locPDAC01 | 82 | M | 224 | 3.6 | 2 | 2 | 0 | III |
locPDAC02 | 49 | F | 566 | 1.1 | 2 | 0 | 0 | I |
locPDAC03 | 70 | M | 40 | 4.7 | 1 | 0 | 0 | I |
locPDAC04 | 72 | M | 82 | 5 | 1 | 2 | 0 | II |
locPDAC05 | 65 | M | 1943 | 4.8 | 2 | 0 | 0 | I |
locPDAC06 | 74 | F | 289 | 2.5 | 3 | 0 | 0 | II |
locPDAC07 | 59 | F | 418 | 2.9 | 2 | 0 | 0 | I |
locPDAC08 | 61 | M | 179 | 2 | 1 | 1 | 0 | II |
locPDAC09 | 60 | M | 132 | 3.2 | 2 | 0 | 0 | I |
locPDAC10 | 89 | F | 11.7 | 24 | 3 | 0 | 0 | II |
locPDAC11 | 50 | F | 1040 | 8.3 | 2 | 0 | 0 | I |
locPDAC12 | 66 | F | 2 | 1.5 | 1 | 0 | 0 | I |
locPDAC13 | 83 | F | 19 | 1.5 | 1 | 2 | 0 | II |
locPDAC14 | 69 | M | 63 | 4.9 | 2 | 1 | 0 | II |
locPDAC15 | 69 | F | 369 | 5.4 | 3 | 2 | 0 | III |
locPDAC16 | 76 | M | 15 | 3.2 | 2 | 0 | 0 | I |
locPDAC17 | 75 | F | 70 | 2.1 | 2 | 0 | 0 | I |
